The epidemiology of peripheral arterial disease

Vascular Medicine

Volumn , Issue , 2006, Pages 223-238

  Criqui, Michael H ^a,b   Ninomiya, John ^b  

^a Department of Family and Preventive Medicine ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37549052275     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0284-4.50020-8     Document Type: Chapter

References (111)

1. Bowlin SJ, Medalie JH, Flocke SA, et al. Epidemiology of intermittent claudication in middle-aged men. Am J Epidemiol 1994, 140:418.
2. Rose GA The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull WHO 1962, 27:645.
3. Criqui MH, Denenberg JO, Bird CE, et al. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med 1996, 1:65.
4. Vogt MT, Cauley JA, Kuller LH, et al. Prevalence and correlates of lower extremity arterial disease in elderly women. Am J Epidemiol 1993, 137:559.
5. Winsor T Influence of arterial disease on the systolic blood pressure gradients of the extremity. Am J Med Sci 1950, 220:117.
6. Hooi JD, Stoffers HE, Kester AD, et al. Peripheral arterial occlusive disease: Prognostic value of signs, symptoms, and the ankle-brachial pressure index. Med Decis Making 2002, 22:99.
7. Meijer WT, Grobbee DE, Hunink MG, et al. Determinants of peripheral arterial disease in the elderly: The Rotterdam study. Arch Intern Med 2000, 160:2934.
8. Meijer WT, Hoes AW, Rutgers D, et al. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998, 18:185.
9. Yao ST, Hobbs JT, Irvine WT Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg 1969, 56:676.
10. Ouriel K, McDonnell AE, Metz CE, et al. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery 1982, 91:686.
11. Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985, 71:510.
12. Criqui MH, Vargas V, Ho E, et al. Ethnicity and peripheral arterial disease: The San Diego Population Study. Presented at the Asia-Pacific Scientific Forum-The Genomics Revolution: Bench to Bedside to Community and the 42nd Annual Conference on Cardiovascular Disease Epidemiology and Prevention, Honolulu, HI, April 26, 2002. Circulation 2002, 105:e113.
13. Newman AB, Siscovick DS, Manolio TA, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993, 88:837.
14. Leng GC, Fowkes FG, Lee AJ, et al. Use of ankle brachial pressure index to predict cardiovascular events and death: A cohort study. BMJ 1996, 313:1440.
15. McDermott MM, Fried L, Simonsick E, et al. Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: The women's health and aging study. Circulation 2000, 101:1007.
16. McDermott MM, Criqui MH, Liu K, et al. Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. J Vasc Surg 2000, 32:1164.
17. McDermott MM, Ferrucci L, Simonsick EM, et al. The ankle brachial index and change in lower extremity functioning over time: The Women's Health andAging Study. J Am Geriatr Soc 2002, 50:238.
18. de GraaffJC, Ubbink DT, Legemate DA, et al. Interobserver and intraobserver reproducibility of peripheral blood and oxygen pressure measurements in the assessment of lower extremity arterial disease. J Vasc Surg 2001, 33:1033.
19. Aboyans V, Lacroix P, Lebourdon A, et al. The intra - and interobserver variability of ankle-arm blood pressure index according to its mode of calculation. J Clin Epidemiol 2003, 56:215.
20. Shadman R, Criqui MH, Bundens WP, et al. Subclavian stenosis: Prevalence, risk factors, and association with other cardiovascular diseases. Presented at the American Federation for Medical Research Western Regional Meeting, Carmel, CA, January 29-February 1, 2003. J Investig Med 2003, 51.
21. Fowkes FG, Housley E, Cawood EH, et al. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991, 20:384.
22. Hiatt WR, Hoag S, Hamman RF Effect of diagnostic criteria on the prevalence of peripheral arterial disease: The San Luis Valley Diabetes Study. Circulation 1995, 91:1472.
23. Kreines K, Johnson E, Albrink M, et al. The course of peripheral vascular disease in non-insulin-dependent diabetes. Diabetes Care 1985, 8:235.
24. Orchard TJ, Strandness DE Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Heart Association and the American Diabetes Association, 18-20 September 1992, New Orleans, Louisiana. Diabetes Care 1993, 16:1199.
25. McKenna M, Wolfson S, Kuller L The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991, 87:119.
26. Newman AB, Shemanski L, Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 1999, 19:538.
27. Murabito JM, Evans JC, Nieto K, et al. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 2002, 143:961.
28. Wang JC, Criqui MH, Denenberg JO, et al. Variations in leg pain in peripheral arterial disease. Presented at the American Federation for Medical Research Western Regional Meeting, Carmel, CA, January 29-February 1, 2003. J Investig Med 2003, 51.
29. Beks PJ, Mackaay AJ, de Neeling JN, et al. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: The Hoorn study. Diabetologia 1995, 38:86.
30. Stoffers HE, Rinkens PE, Kester AD, et al. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol 1996, 25:282.
31. Curb JD, Masaki K, Rodriguez BL, et al. Peripheral artery disease and cardiovascular risk factors in the elderly. The Honolulu Heart Program. ArteriosclerThromb Vasc Biol 1996, 16:1495.
32. Kannel WB, McGee DL Update on some epidemiologic features of intermittent claudication: The Framingham Study. J Am Geriatr Soc 1985, 33:13.
33. Dagenais GR, Maurice S, Robitaille NM, et al. Intermittent claudication in Quebec men from 1974-1986: The Quebec Cardiovascular Study. Clin Invest Med 1991, 14:93.
34. Bainton D, Sweetnam P, Baker I, et al. Peripheral vascular disease: Consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J 1994, 72:128.
35. Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996, 25:1172.
36. Ingolfsson IO, Sigurdsson G, Sigvaldason H, et al. A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: A strong relationship to smoking and serum cholesterol-the Reykjavik Study. J Clin Epidemiol 1994, 47:1237.
37. Hooi JD, Kester AD, Stoffers HE, et al. Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: A longitudinal study. Am J Epidemiol 2001, 153:666.
38. Gallotta G, Iazzetta N, Milan G, et al. Prevalence of peripheral arterial disease in an elderly rural population of southern Italy. Gerontology 1997, 43:289.
39. Zheng ZJ, Sharrett AR, Chambless LE, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and pre-clinical carotid and popliteal atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 1997, 131:115.
40. McDermott MM, Liu K, Criqui MH The ankle-brachial index and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis. Presented at the 43rd Annual Conference on Cardiovascular Disease Epidemiology and Prevention, Miami, FL, March 6, 2003. Circulation 2003, 107:e7001.
41. Faulkner KW, House AK, Castleden WM The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease. Med J Aust 1983, 1:217.
42. Quick CR, Cotton LT The measured effect of stopping smoking on intermittent claudication. Br J Surg 1982, 69(Suppl):S24.
43. Jonason T, Bergstrom R Cessation of smoking in patients with intermittent claudication: Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand 1987, 221:253.
44. Fowkes FG, Housley E, Riemersma RA, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992, 135:331.
45. Murabito JM, D'Agostino RB, Silbershatz H, et al. Intermittent claudication: A risk profile from The Framingham Heart Study. Circulation 1997, 96:44.
46. Katsilambros NL, Tsapogas PC, Arvanitis MP, et al. Risk factors for lower extremity arterial disease in non-insulin-dependent diabetic persons. Diabet Med 1996, 13:243.
47. Tseng CH Prevalence and risk factors of peripheral arterial obstructive disease in Taiwanese type 2 diabetic patients. Angiology 2003, 54:331.
48. Kallio M, Forsblom C, Groop PH, et al. Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. Diabetes Care 2003, 26:1241.
49. Jude EB, Oyibo SO, Chalmers N, et al. Peripheral arterial disease in diabetic and nondiabetic patients: A comparison of severity and outcome. Diabetes Care 2001, 24:1433.
50. Haltmayer M, Mueller T, Horvath W, et al. Impact of atherosclerotic risk factors on the anatomical distribution of peripheral arterial disease. Int Angiol 2001, 20:200.
51. Ness J, Aronow WS, Ahn C Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice. J Am Geriatr Soc 2000, 48:312.
52. Ridker PM, Stampfer MJ, Rifai N Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001, 285:2481.
53. Fowkes FG Epidemiology of atherosclerotic arterial disease in the lower limbs. Eur J Vasc Surg 1988, 2:2831.
54. Cheng SW, Ting AC, Wong J Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease. Ann Vasc Surg 1997, 11:217.
55. Smith I, Franks PJ, Greenhalgh RM, et al. The influence of smoking cessation and hypertriglyceridaemia on the progression of peripheral arterial disease and the onset of critical ischaemia. Eur J Vasc Endovasc Surg 1996, 11:402.
56. Mowat BF, Skinner ER, Wilson HM, et al. Alterations in plasma lipids, lipoproteins and high density lipoprotein subfractions in peripheral arterial disease. Atherosclerosis 1997, 131:161.
57. Criqui MH, Deneberg JO, Langer RD, et al. Peripheral arterial disease and hypertension. Hypertension Primer 2003, 250. American Heart Association, Dallas. J.L. Izzo, H.R. Black (Eds.).
58. Dormandy J, Heeck L, Vig S Predictors of early disease in the lower limbs. Semin Vasc Surg 1999, 12:109.
59. Tseng CH Prevalence and risk factors of peripheral arterial obstructive disease in Taiwanese type 2 diabetic patients. Angiology 2003, 54:331.
60. Vliegenthart R, Geleijnse JM, Hofman A, et al. Alcohol consumption and risk of peripheral arterial disease: The Rotterdam Study. Am J Epidemiol 2002, 155:332.
61. Jepson RG, Fowkes FG, Donnan PT, et al. Alcohol intake as a risk factor for peripheral arterial disease in the general population in the Edinburgh Artery Study. Eur J Epidemiol 1995, 11:9.
62. Fabsitz RR, Sidawy AN, Go O, et al. Prevalence of peripheral arterial disease and associated risk factors inAmerican Indians: The Strong Heart Study. Am J Epidemiol 1999, 149:330.
63. Camargo CA, Stampfer MJ, Glynn RJ, et al. Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in U.S. male physicians. Circulation 1997, 95:577.
64. Hobbs SD, Wilmink AB, Bradbury AW Ethnicity and peripheral arterial disease. Eur J Vasc Endovasc Surg 2003, 25:505.
65. Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995, 274:1049.
66. Bloemenkamp DG, van den Bosch MA, Mali WP, et al. Novel risk factors for peripheral arterial disease in young women. Am J Med 2002, 113:462.
67. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997, 277:1775.
68. Hoogeveen EK, Kostense PJ, Beks PJ, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: A population-based study. Arterioscler Thromb Vasc Biol 1998, 18:133.
69. Taylor LM, Moneta GL, Sexton GJ, et al. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vasc Surg 1999, 29:8.
70. Hung HC, Willett W, Merchant A, et al. Oral health and peripheral arterial disease. Circulation 2003, 107:1152.
71. Whiteman MC, Deary IJ, Fowkes FG Personality and social predictors of atherosclerotic progression: Edinburgh Artery Study. Psychosom Med 2000, 62:703.
72. McDermott MM, Greenland P, Guralnik JM, et al. Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease. J Gen Intern Med 2003, 18:461.
73. Carmelli D, Fabsitz RR, Swan GE, et al. Contribution of genetic and environmental influences to ankle-brachial blood pressure index in the NHLBI Twin Study. National Heart, Lung, and Blood Institute. Am J Epidemiol 2000, 151:452.
74. Kroon AA, Ajubi N, van Asten WN, et al. The prevalence of peripheral vascular disease in familial hypercholesterolaemia. J Intern Med 1995, 238:451.
75. Taylor LM, Chitwood RW, Dalman RL, et al. Antiphospholipid antibodies in vascular surgery patients: A cross-sectional study. Ann Surg 1994, 220:544.
76. Lam EY, Taylor LM, Landry GJ, et al. Relationship between antiphospholipid antibodies and progression of lower extremity arterial occlusive disease after lower extremity bypass operations. J Vasc Surg 2001, 33:976.
77. Mya MM, Aronow WS Increased prevalence of peripheral arterial disease in older men and women with subclinical hypothyroidism. J Gerontol A Biol Sci Med Sci 2003, 58:68.
78. Asgeirsdottir LP, Agnarsson U, Jonsson GS Lower extremity blood flow in healthy men: Effect of smoking, cholesterol, and physical activity-a Doppler study. Angiology 2001, 52:437.
79. Klipstein-Grobusch K, den Breeijen JH, Grobbee DE, et al. Dietary antioxidants and peripheral arterial disease: The Rotterdam Study. Am J Epidemiol 2001, 154:145.
80. Westendorp IC, in't Veld BA, Grobbee DE, et al. Hormone replacement therapy and peripheral arterial disease: The Rotterdam Study. Arch Intern Med 2000, 160:2498.
81. Hsia J, Criqui MH, Rodabough R, et al. Estrogen plus progestin and the risk of peripheral arterial disease: The Women's Health Initiative. Circulation 2004, 109:620.
82. Bird CE, Criqui MH, Fronek A, et al. Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing. Vasc Med 1999, 4:15.
83. Fowkes FG, Lowe GD, Housley E, et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993, 342:84.
84. NicoloffAD, Taylor LM, Sexton GJ, et al. Relationship between site of initial symptoms and subsequent progression of disease in a prospective study of atherosclerosis progression in patients receiving long-term treatment for symptomatic peripheral arterial disease. J Vasc Surg 2002, 35:38.
85. Taute BM, Glaser C, Taute R, et al. Progression of atherosclerosis in patients with peripheral arterial disease as a function of angiotensin-converting enzyme gene insertion/deletion polymorphism. Angiology 2002, 53:375.
86. Walsh DB, Gilbertson JJ, Zwolak RM, et al. The natural history of superficial femoral artery stenoses. J Vasc Surg 1991, 14:299.
87. Jelnes R, Gaardsting O, Hougaard Jensen K, et al. Fate in intermittent claudication: Outcome and risk factors. Br Med J (Clin Res Ed) 1986, 293:1137.
88. Smith FB, Lowe GD, Lee AJ, et al. Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication. J Vasc Surg 1998, 28:129.
89. McCready RA, Vincent AE, Schwartz RW, et al. Atherosclerosis in the young: A virulent disease. Surgery 1984, 96:863.
90. Pairolero PC, Joyce JW, Skinner CR, et al. Lower limb ischemia in young adults: Prognostic implications. J Vasc Surg 1984, 1:459.
91. Hallett JW, Greenwood LH, Robison JG Lower extremity arterial disease in young adults: A systematic approach to early diagnosis. Ann Surg 1985, 202:647.
92. Valentine RJ, MacGillivray DC, DeNobile JW, et al. Intermittent claudication caused by atherosclerosis in patients aged forty years and younger. Surgery 1990, 107:560.
93. Levy PJ, Hornung CA, Haynes JL, et al. Lower extremity ischemia in adults younger than forty years of age: A community-wide survey of premature atherosclerotic arterial disease. J Vasc Surg 1994, 19:873.
94. Criqui MH, Denenberg JO, Langer RD, et al. The epidemiology of peripheral arterial disease: Importance of identifying the population at risk. Vasc Med 1997, 2:221.
95. Ness J, Aronow WS Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc 1999, 47:1255.
96. Alexandrova NA, Gibson WC, Norris JW, et al. Carotid artery stenosis in peripheral vascular disease. J Vasc Surg 1996, 23:645.
97. Pilcher JM, Danaher J, Khaw KT The prevalence of asymptomatic carotid artery disease in patients with peripheral vascular disease. ClinRadiol 2000, 55:56.
98. Long TH, Criqui MH, Vasilevskis EE, et al. The correlation between the severity of peripheral arterial disease and carotid occlusive disease. Vasc Med 1999, 4:135.
99. Kannel WB, Skinner JJ, Schwartz MJ, et al. Intermittent claudication: Incidence in the Framingham Study. Circulation 1970, 41:875.
100. Kannel WB, ShurtleffD The natural history of arteriosclerosis obliterans. Cardiovasc Clin 1971, 3:37.
101. Reunanen A, Takkunen H, Aromaa A Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand 1982, 211:249.
102. Kallero KS Mortality and morbidity in patients with intermittent claudication as defined by venous occlusion plethysmography: A ten-year follow-up study. J Chronic Dis 1981, 34:455.
103. Smith GD, Shipley MJ, Rose G Intermittent claudication, heart disease risk factors, and mortality: The Whitehall Study. Circulation 1990, 82:1925.
104. Criqui MH, Coughlin SS, Fronek A Noninvasively diagnosed peripheral arterial disease as a predictor of mortality: Results from a prospective study. Circulation 1985, 72:768.
105. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992, 326:381.
106. McDermott MM, Feinglass J, Slavensky R, et al. The ankle-brachial index as a predictor of survival in patients with peripheral vascular disease. J Gen Intern Med 1994, 9:445.
107. Newman AB, Sutton-Tyrrell K, Vogt MT, et al. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 1993, 270:487.
108. Vogt MT, Cauley JA, Newman AB, et al. Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA 1993, 270:465.
109. Kornitzer M, Dramaix M, Sobolski J, et al. Ankle/arm pressure index in asymptomatic middle-aged males: An independent predictor of ten-year coronary heart disease mortality. Angiology 1995, 46:211.
110. Criqui MH, Langer RD, Fronek A, et al. Coronary disease and stroke in patients with large-vessel peripheral arterial disease. Drugs 42 Suppl 1991, 5:16.
111. Tsai AW, Folsom AR, Rosamond WD, et al. Ankle-brachial index and 7-year ischemic stroke incidence: The ARIC study. Stroke 2001, 32:1721.